Leukemia: all 5,475 studies
Page 25 of 55. Open to participants first (629), then studies with results posted, then the rest; newest registration first within each.
- Efficacy and Safety Evaluation of IBI188 in Combination With Demethylating Agents in Treatment of Patients With Acute Myeloid LeukemiaSuspendedNCT04485052Phase 1/2
- Palliative Care Oncology in Patients With Relapsed, Refractory, and High-Risk Leukemias or MDSActive, not recruitingNCT04482894Not applicable
- CD7-CART in the Treatment of r / r CD7 Positive Hemolymph System Malignancies on Increasing Dose and Open Label StudyStatus unknownNCT04480788Phase 1
- A Study of CG-806 in Patients With Relapsed or Refractory AML or Higher-Risk MDSTerminatedNCT04477291Phase 1
- Venetoclax and Decitabine Assessment in Patients (≥60 - <75 Years) with Newly Diagnosed AML Eligible for Allo-SCTActive, not recruitingNCT04476199Phase 2
- Ponatinib in Adult Ph+ ALL Patients With MRD Positivity or Hematological RelapseActive, not recruitingNCT04475731Phase 2
- Healthy Bones, Healthy Life: Habitual Physical Activity on Bone & Metabolic Health in Pediatric Cancer SurvivorsCompletedNCT04472286
- HA-1H TCR T Cell for Relapsed/Persistent Hematologic Malignancies After Allogeneic Stem Cell TransplantationWithdrawnNCT04464889Phase 1
- Hypomethylating Agents and Venetoclax in Newly Diagnosed Acute Myeloid Leukemia Patients Not Eligible for Intensive ChemotherapyStatus unknownNCT04454580
- Multicentric Registry of Patients With Acute Leukemia Infected by COVID-19CompletedNCT04452604
- ObServatory Children Acute RElated Therapy LeukemiaStatus unknownNCT04450784
- Blincyto Amgen Acrotech BioPharma PH2 Blincyto Marqibo R/R Philadelphi CD19+ ALLWithdrawnNCT04448834Phase 2
- Molecular Diagnostic Platform for AMLStatus unknownNCT04446741
- Study of Decitabine Combined With HAAG Regimen in Newly Diagnosed ETP-ALL/LBL, T/M-MPAL and ALL/LBL With Myeloid or Stem Cell Markers PatientsStatus unknownNCT04446130Phase 3
- Phase III rhu_GM-CSF + 3 Induction Regimens in Adults With Acute Non-Lymphocytic LeukemiaCompletedNCT04446052Phase 3
- γδT Cell Infusion to Prevent Relapsed/Refractory Leukemia Rescue RelapseStatus unknownNCT04439721Early Phase 1
- Preclinical Project on the Traitment of Acute Lymphoblastique Leukemia With NVP-BEP800, an Inhibitor of the Heat Shock Protein HSP90Status unknownNCT04437420
- A Safety and Preliminary Efficacy Study of CC-99282 in Combination With Obinutuzumab in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaCompletedNCT04434196Phase 1
- Fludarabine in Combination With Daunorubicin and Cytarabine Liposome in Newly-diagnosed Acute Myeloid Leukemia.TerminatedNCT04425655Phase 2
- Efficacy and Safety of HVA Regimens as Salvage Treatment in rrAMLCompletedNCT04424147Phase 2
- Safety and Efficacy of ALLO-501A Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell Lymphoma, Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (ALPHA2)Active, not recruitingNCT04416984Phase 1/2
- Efficacy of HAD Induction With Intensified Cytarabine in Newly-diagnosed CEBPA Double Mutated Acute Myeloid LeukemiaActive, not recruitingNCT04415008Phase 2
- Endogenous Retroviruses in Acute Myeloid LeukemiaWithdrawnNCT04406207
- Study of CB-5339 in Acute Myeloid Leukemia or Myelodysplastic SyndromeCompletedNCT04402541Phase 1
- ETOILE : A Feasibility Study in Pediatric Patient EducationCompletedNCT04399863Not applicable
- Outcomes of Acute Myeloid Leukemia PatientsStatus unknownNCT04392310
- Observatory of Patients With Chronic Lymphocytic Leukemia / Lymphocytic Lymphoma or Waldenstrom Disease Infected With COVID-19CompletedNCT04391946
- Study of Efficacy and Safety of Flumatinib Combined With Chemotherapy in Ph Positive ALLStatus unknownNCT04375683Phase 3
- Decitabine+Cladribine+Cytarabine+Granulocyte Colony-stimulating Factor (D-CLAG) for Relapsed or Refractory Acute Myeloid Leukemia (AML)Status unknownNCT04373395Not applicable
- Prevalence and Clinical Effect of IDH1/2 Mutations in Patients With Acute Myeloid LeukemiaStatus unknownNCT04369287
- Correlation of Polymorphisms of Lipoprotein Lipase (LpL) and Apolipoprotein E (Apo E) With Lipid Profile of Children With Acute Lymphoblastic Eukaemia During Therapy With L - Asparaginase.Status unknownNCT04364451
- Nivolumab for High-Risk MDS/AML Patients After Allogeneic Stem Cell Transplant With Post-Transplant CyclophosphamideWithdrawnNCT04361058Phase 1
- Cytokine-induced Memory-like NK Cells in Combination With Chemotherapy in Pediatric Patents With Refractory or Relapsed AMLWithdrawnNCT04354025Phase 2
- Combined PD1 Inhibitor and Decitabine in Elderly Patients With Relapse and Refractory Acute Myeloid LeukemiaStatus unknownNCT04353479Phase 2
- CD38-targeted Chimeric Antigen Receptor T Cell (CART) in Relapesd or Refractory Acute Myeloid LeukemiaStatus unknownNCT04351022Phase 1/2
- Tagraxofusp in Patients With CD123+ or With BPDCN-IPh-like Acute Myeloid LeukemiaTerminatedNCT04342962Phase 2
- Observational Trial of Real-World Treatment Utilization and Effectiveness of PI3K-inhibitors in CLL/SLL and FLTerminatedNCT04342117
- Study of Anti-CD22 CAR-T Cells Treating Leukemia ChildrenCompletedNCT04340167Phase 2
- A Safety and Efficacy Study of CC-90009 Combinations in Subjects With Acute Myeloid LeukemiaTerminatedNCT04336982Phase 1
- Safety of Expanded Haploidentical Natural Killer Cells for LeukemiaCompletedNCT04327037Phase 1
- Phase II Study of Anti-CD19 CAR-T Cells Treating Leukemia ChildrenCompletedNCT04325841Phase 2
- TC-110 T Cells in Adults With Relapsed or Refractory Non-Hodgkin Lymphoma or Acute Lymphoblastic LeukemiaCompletedNCT04323657Phase 1/2
- Continuous Ambulatory Monitoring to Predict Elevated Risk of Infection in Children With Lymphoblastic Leukemia Undergoing Induction Chemotherapy (CAMPER-ALL)WithdrawnNCT04322084
- Impact of the Use of Zinc in the Prevention of Oral Mucositis in Pediatric Patients With Lymphoblastic Acute Leukemia.TerminatedNCT04321850Not applicable
- Analysis of T Cell Metabolism in Relapsed AML Patients With DLIs and Bicanorm TreatmentCompletedNCT04321161Early Phase 1
- Natural Killer Cell (CYNK-001) Infusions in Adults with AMLTerminatedNCT04310592Phase 1
- Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's LymphomasTerminatedNCT04305444Phase 2
- Pharmacoeconomics in the Application of 5-azacitidine in the Treatment of Myelodysplastic Syndromes and Acute Myeloid LeukemiaWithdrawnNCT04296214
- Anti-CD19 CAR in PiggyBac Transposon-Engineered T Cells for Relapsed/Refractory B-cell Lymphoma or B-cell Acute Lymphoblastic LeukemiaStatus unknownNCT04289220Phase 1
- Immunophenotyping and Xist Gene in AMLStatus unknownNCT04288739
- Observational Study Relapsed or Refractory Chronic Lymphocytic Leukemia Venetoclax-based Regimens Outside Clinical Trials in ItalyActive, not recruitingNCT04282811
- A Study of TAS1440 With ATRA in Subjects With r/r AMLTerminatedNCT04282668Phase 1
- CD34+ Enriched Transplants From HLA-Compatible Patients With Hematologic MalignanciesWithdrawnNCT04282174Phase 2
- A Study of HMPL-306 in Patients With IDH1 and/or IDH2 Mutation of Relapsed/Refractory Myeloid Leukemia/NeoplasmsStatus unknownNCT04272957Phase 1
- Safety and Efficacy of CD19-Targeted CAR-T Therapy for Relapsed/Refractory CD19+ B Cell Leukemia and LymphomaStatus unknownNCT04271800Phase 1/2
- Overweight and Obesity as Prognostic Factors for Survival in Children With Acute Lymphoblastic LeukemiaStatus unknownNCT04271215
- Study of Venetoclax in Combination With Azacytidine in AML Patients Selected Using Ex Vivo Drug Sensitivity ScreeningCompletedNCT04267081Phase 2
- CD123-Targeted CAR-T Cell Therapy for Relapsed/Refractory Acute Myeloid LeukemiaStatus unknownNCT04265963Phase 1/2
- A Study of Cusatuzumab in Combination With Azacitidine Compared With Azacitidine Alone in Patients With Higher-risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) and Who Are Not Candidates for Hematopoietic Stem Cell Transplantation (HSCT)WithdrawnNCT04264806Phase 2
- CD19/CD20 Dual-CAR-T in B-cell Leukemia PatientsCompletedNCT04260945Phase 1
- Analysis of T Cell Metabolism in Acute Myeloid Leukemia PatientsCompletedNCT04259372
- Efficacy and Safety of Cladribine in Combination With CAG in Newly Diagnosed Unfit Patients With AMLStatus unknownNCT04254640Phase 2
- A Study of the Effectiveness of Venetoclax Tablets in Adult Acute Myeloid Leukemia Participants Ineligible for Standard Induction Therapy in Russian FederationCompletedNCT04253314
- Study of Azacitidine Combined With Homoharringtonie Based Regimens in AMLStatus unknownNCT04248595Phase 2
- FT596 as a Monotherapy and in Combination With Anti-CD20 Monoclonal AntibodiesTerminatedNCT04245722Phase 1
- A Study of Cusatuzumab Plus Azacitidine in Japanese Participants With Newly Diagnosed Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome Who Are Not Candidates for Intensive TreatmentCompletedNCT04241549Phase 1
- Effect of a Hyperproteic Hyperenergetic Enteral Formula on Body Composition and VEGF in AML During Hospital StayStatus unknownNCT04240600Not applicable
- Matched Unrelated vs. Haploidentical Donor for Allogeneic Stem Cell Transplantation in Patients With Acute LeukemiaActive, not recruitingNCT04232241Phase 2
- Acute Myeloid Leukemia Real World Treatment PatternsWithdrawnNCT04230564
- A Clinical Trial of CNCT19 Cells in the Treatment of CD19 Positive Relapsed or Refractory Acute Lymphoblastic LeukemiaCompletedNCT04230473Phase 1
- The Individualized Treatment of 6-mercaptopurine in Children With Acute Lymphoblastic Leukemia in ChinaStatus unknownNCT04228393Phase 2/3
- CCCG Relapsed Acute Lymphoblastic Leukemia 2017 Study in ChildrenCompletedNCT04224571Phase 2
- NK Cell Infusion for Patients With Acute Myeloid LeukemiaStatus unknownNCT04221971Phase 1
- SNS-301 Monotherapy in High Risk MDS and CMMLWithdrawnNCT04217720Phase 2
- PHF19 Gene Expression and EZH2 Gene Deletion in Acute Myeloid LeukemiaStatus unknownNCT04215822
- Dietary Intervention With High Phenolic EVOO in CLLCompletedNCT04215367Not applicable
- Natural Killer Cells Infusion for Treating Acute Myeloid Leukemia Patients With Minimal Residual DiseaseStatus unknownNCT04209712Early Phase 1
- Talazoparib and Gemtuzumab Ozogamicin for the Treatment of CD33 Positive Relapsed or Refractory Acute Myeloid LeukemiaCompletedNCT04207190Phase 1
- Study of CD19 Specific Chimeric Antigen Receptor Positive T Cells (CAR-T) in ALL and NHLStatus unknownNCT04206943Phase 1/2
- A Clinical Study of CAR-T Cells Treatment for Children With CD19+/CD22+ R/R ALL and LymphomaStatus unknownNCT04204161Phase 1
- A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of TJ011133 as Monotherapy and in Combination With Azacitidine (AZA) in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)CompletedNCT04202003Phase 1/2
- Evaluation of Therapeutic Video Games for Pre-school Children With Acute Lymphoblastic LeukemiaCompletedNCT04199637Not applicable
- A Study of the Safety and Efficacy of Venetoclax in Japanese Participants With Relapsed and Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Leukemia)CompletedNCT04198415
- Continuous Infusion Chemotherapy (CI-CLAM) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Other High-Grade Myeloid NeoplasmsTerminatedNCT04196010Phase 1
- Population Pharmacokinetics and Safety of Oral Posaconazole in Children With LeukemiaCompletedNCT04194086Phase 1/2
- Resiliency in Older Adults Undergoing Bone Marrow TransplantCompletedNCT04188678
- Cefepime vs Ceftazidime as Empirical Therapy for Neutropenic FeverCompletedNCT04187755Phase 4
- The Association Between Asparaginase Enzyme Activity Levels and Toxicities in Childhood Acute Lymphoblastic Leukaemia in NOPHOALL 2008CompletedNCT04187248
- Investigating Integrative Therapies for Symptom Management in Adults With Acute LeukemiaTerminatedNCT04185428Not applicable
- Monitoring the Diagnosis and Management of Acute Leukaemia In Pregnancy Study.CompletedNCT04182074
- Study to Investigate the Use of Acalabrutinib in the Treatment of Patients With Chronic Lymphocytic LeukemiaCompletedNCT04178798Phase 3
- A China Bridging Study of Ivosidenib in r/r AML Subjects With an IDH1 MutationCompletedNCT04176393Phase 1
- Randomized,International Multi-center Clinical Trial of RIF Plus RA for Non-high-risk APLStatus unknownNCT04175587Phase 3
- Pevonedistat, Azacitidine (or Decitabine), and Venetoclax for the Treatment of Patients With Acute Myelogenous LeukemiaTerminatedNCT04172844Phase 1
- D-CTAG in the Treatment of Newly Diagnosed Acute Myeloid Leukemia in Elderly PatientsStatus unknownNCT04168138Not applicable
- Haploidentical Stem Cell Transplant With or Without NK Cell Infusion in AML and MDSTerminatedNCT04166929Phase 2
- The Clinical Study of CD19 UCAR-T Cells in Patients With B-cell Acute Lymphoblastic Leukemia (B-ALL)Status unknownNCT04166838Early Phase 1
- Integrating Geriatric Assessment for Older Patients Diagnosed With Acute Myelogenous LeukemiaCompletedNCT04158726Not applicable
- A Retrospective Study of Patients With Leukemia Relapse in the CNS Treated With CAR T CellsStatus unknownNCT04158011
- Study of Tisagenlecleucel in Chinese Pediatric and Young Adult Subjects With Relapsed or Refractory B-cell ALLWithdrawnNCT04156659Phase 2